Lisata Therapeutics Statistics
Total Valuation
LSTA has a market cap or net worth of $30.26 million. The enterprise value is $17.20 million.
Important Dates
The last earnings date was Monday, May 11, 2026, after market close.
| Earnings Date | May 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
LSTA has 9.03 million shares outstanding. The number of shares has increased by 4.54% in one year.
| Current Share Class | 9.03M |
| Shares Outstanding | 9.03M |
| Shares Change (YoY) | +4.54% |
| Shares Change (QoQ) | +2.33% |
| Owned by Insiders (%) | 21.06% |
| Owned by Institutions (%) | 11.76% |
| Float | 7.13M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 177.99 |
| Forward PS | n/a |
| PB Ratio | 2.79 |
| P/TBV Ratio | 2.77 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 101.17 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.23
| Current Ratio | 4.23 |
| Quick Ratio | 3.94 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -91.41% and return on invested capital (ROIC) is -60.31%.
| Return on Equity (ROE) | -91.41% |
| Return on Assets (ROA) | -50.26% |
| Return on Invested Capital (ROIC) | -60.31% |
| Return on Capital Employed (ROCE) | -161.06% |
| Weighted Average Cost of Capital (WACC) | 8.69% |
| Revenue Per Employee | $8,095 |
| Profits Per Employee | -$778,619 |
| Employee Count | 21 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -387,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +25.94% in the last 52 weeks. The beta is 0.81, so LSTA's price volatility has been lower than the market average.
| Beta (5Y) | 0.81 |
| 52-Week Price Change | +25.94% |
| 50-Day Moving Average | 3.71 |
| 200-Day Moving Average | 3.14 |
| Relative Strength Index (RSI) | 48.11 |
| Average Volume (20 Days) | 94,196 |
Short Selling Information
The latest short interest is 93,493, so 1.04% of the outstanding shares have been sold short.
| Short Interest | 93,493 |
| Short Previous Month | 70,246 |
| Short % of Shares Out | 1.04% |
| Short % of Float | 1.31% |
| Short Ratio (days to cover) | 1.31 |
Income Statement
In the last 12 months, LSTA had revenue of $170,000 and -$16.35 million in losses. Loss per share was -$1.86.
| Revenue | 170,000 |
| Gross Profit | 170,000 |
| Operating Income | -17.30M |
| Pretax Income | -16.74M |
| Net Income | -16.35M |
| EBITDA | -17.20M |
| EBIT | -17.30M |
| Loss Per Share | -$1.86 |
Full Income Statement Balance Sheet
The company has $13.06 million in cash and n/a in debt, with a net cash position of $13.06 million or $1.45 per share.
| Cash & Cash Equivalents | 13.06M |
| Total Debt | n/a |
| Net Cash | 13.06M |
| Net Cash Per Share | $1.45 |
| Equity (Book Value) | 10.67M |
| Book Value Per Share | 1.20 |
| Working Capital | 10.71M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -13.63M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 105,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -13.63M |
| FCF Per Share | -$1.51 |
Full Cash Flow Statement Margins
| Gross Margin | 100.00% |
| Operating Margin | -10,178.82% |
| Pretax Margin | -9,845.88% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
LSTA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.54% |
| Shareholder Yield | -4.54% |
| Earnings Yield | -54.04% |
| FCF Yield | -45.05% |
Analyst Forecast
The average price target for LSTA is $4.00, which is 19.40% higher than the current price. The consensus rating is "Hold".
| Price Target | $4.00 |
| Price Target Difference | 19.40% |
| Analyst Consensus | Hold |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 248.57% |
| EPS Growth Forecast (3Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 15, 2022. It was a reverse split with a ratio of 1:15.
| Last Split Date | Sep 15, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |